Oculoplastic Surgery Market Size to Reach USD 10.1 Bn by 2025

Global Oculoplastic Surgery Market By Procedure (Eyelid Surgery, Orbital Surgery, Face Lift, Brow Lift & Forehead Lift and Pediatric Oculoplastic surgery) By End Use (Ambulatory surgical centers and Hospitals & clinics) By Region, Industry Analysis and Forecast, 2019 - 2025

Published Date: January-2020 | Number of Pages: 159 | Format: PDF | Report ID: KBV-12522

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the Oculoplastic Surgery Market

Market Report Description

The Global Oculoplastic Surgery Market size is expected to reach $10.1 billion by 2025, rising at a market growth of 5.75% CAGR during the forecast period. Typically, oculoplastic surgery is performed to enhance patients' overall appearance. Oculoplastic surgery is a plastic surgery conducted on areas like eyelids and facial tear ducts. Anomalies such as eye defects, damage to the eye socket, thyroid disease, orbital disease and issues with tearing are corrected in sequence.

Global Oculoplastic Surgery Market Size

Oculoplastic Surgery Market Size

Oculoplastic surgeons are ophthalmologists specializing in cosmetic and reconstructive periorbital and facial tissue surgery on the eyelids, ears, cheeks, eyebrows, orbit (bony cavity around the eye) and lacrimal (tear) processes. The field of oculoplastic surgery takes much of the plastic surgery principle and applies it to ophthalmology on a micro-scale (microsurgery). The overall emphasis is on the reconstructive or cosmetic enhancement of the eyelids, orbit, tear ducts, and lids and brows. Most oculoplastic surgeons also use injectable such as botulism toxin and/or facial fillers to rejuvenate the faces.

Oculoplastic Surgery Market Share

Oculoplastic Surgery Market Share

There are many forms of eyelid lesions, some can be easily examined while others should be biopsied or excised entirely. A decision can be made about whether to diagnose, biopsy, or remove the lesion depending on the appearance in consultation and the patient's medical history. Chalazion (stye), skin tags, cysts, and nevi (moles) are among the most common benign eyelid lesions.

Brow and forehead lift examines the positioning of the eyebrow and loose or wrinkled skin of the forehead. Brow shape varies between males and females; males have relatively minimal arching brows resting just above their orbit's bone. Females tend to have a more prominent arch in their brows and prefer to rest above their orbit's bone. Brow lifting can be done simultaneously with blepharoplasty, and in some cases is covered by insurance. The advantage of combining a brow lift with blepharoplasty is that the brows are realigned at a more natural and youthful position which reduces the amount of upper eyelid skin needed to be removed.

Based on Procedure, the market is segmented into Eyelid Surgery, Orbital Surgery, Face Lift, Brow Lift & Forehead Lift and Pediatric Oculoplastic surgery. Based on End Use, the market is segmented into Ambulatory surgical centers and Hospitals & clinics. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

Free Valuable Insights: Global Oculoplastic Surgery Market to reach a market size of $10.1 billion by 2025

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Karl Storz SE & Co. KG, Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH), Stanford Health Care, Tekno-Medical Optik-Chirurgie GmbH, Bolton Surgical Ltd., Blink Medical Ltd. (Katena Products, Inc.), and Sklar Corporation.

Scope of the Oculoplastic Surgery Market Analysis

Market Segmentation:

By Procedure

  • Eyelid Surgery
  • Orbital Surgery
  • Face Lift
  • Brow Lift & Forehead Lift
  • Pediatric Oculoplastic surgery

By End Use

  • Ambulatory surgical centers
  • Hospitals & clinics

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation
  • Karl Storz SE & Co. KG
  • Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH)
  • Stanford Health Care
  • Tekno-Medical Optik-Chirurgie GmbH
  • Bolton Surgical Ltd.
  • Blink Medical Ltd. (Katena Products, Inc.)
  • Sklar Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Oculoplastic Surgery Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market


According to a new report published by KBV Research, The global oculoplastic surgery market size is expected to reach $10.1 billion by 2025.

The major factors that are anticipated to drive the oculoplastic surgery industry include innovations in blepharoplasty, increased prevalence of eye-related disorders and droopy eyes.

The expected CAGR of oculoplastic surgery market is 5.75% from 2019 to 2025.

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities